Will Nasdaq's Beat Streak Continue This Earnings Season?

This is more of a quality-of-earnings setup than a pure top-line story. The market should pay for the mix shift toward recurring, data, compliance, and workflow revenue, because that mix can support a higher multiple even if transaction revenue merely tracks activity. The catch is that headline volume strength can overstate earnings power: lower revenue per contract and higher operating expense mean the print only matters if management shows the recurring businesses are carrying enough incremental margin to offset pricing pressure.

Relative beneficiaries are the other exchange/data names, but the implications differ. CBOE gets the cleanest near-term beta to elevated trading activity, while NDAQ is the better “compounder” if client retention and cross-sell remain intact; SPGI benefits indirectly from capital-markets and data monetization, though it is less levered to a single quarter’s volumes. Second-order, any sustained pickup in listings and market-data usage tends to favor vendors with sticky distribution and low client churn, while pure transaction names remain more exposed to a fade in volatility.

The contrarian point is that consensus may be too focused on the EPS beat and not enough on expense inflation and buyback support. Over the next 1-3 months, the key catalyst is whether guidance confirms mid-teens recurring growth; over 6-18 months, the real question is whether current activity normalizes back to a lower-growth regime. Falsifier: a guide that implies revenue growth decelerating despite active markets, or margin expansion that depends mainly on repurchases rather than operating leverage.